https://pharmadog.xyz/news/388572 pharmadog en 2026-09-10T16:47:22.000Z Study finds doctors still accept pharma gifts and speaking fees despite ongoing debate https://pharmadog.xyz/news/388395 pharmadog en 2026-09-10T16:13:00.000Z FDA issues partial hold on Biohaven’s experimental epilepsy drug opakalim, pausing recruitment in late-stage trial https://pharmadog.xyz/news/388396 pharmadog en 2026-09-10T15:24:00.000Z Takeda R&D chief Andy Plump to retire in June 2027, will stay on board through 2027 https://pharmadog.xyz/news/388291 pharmadog en 2026-09-10T15:06:53.000Z Shionogi's mid-stage stroke drug redasemtide fails, while Bayer's Hyrnuo receives expanded NSCLC label https://pharmadog.xyz/news/388183 pharmadog en 2026-09-10T15:01:04.000Z Lonza announces new spray-drying plant in Bend, Oregon as Samsung Bio secures $262 million contract https://pharmadog.xyz/news/388227 pharmadog en 2026-09-10T14:53:06.000Z Trump officials turn to AI to address rural health care challenges as nominees await Senate confirmation https://pharmadog.xyz/news/388184 pharmadog en 2026-09-10T14:30:21.000Z Biotech industry rebounds as Endpoints 11 awards return in Boston https://pharmadog.xyz/news/388185 pharmadog en 2026-09-10T14:24:11.000Z ARPA-H launches ADVOCATE program to fund AI agents for health tech companies https://pharmadog.xyz/news/388059 pharmadog en 2026-09-10T14:04:36.000Z FDA pauses enrollment in Biohaven's epilepsy trials after earlier depression trial failure https://pharmadog.xyz/news/388015 pharmadog en 2026-09-10T13:58:04.000Z FDA imposes partial clinical hold on Biohaven's experimental epilepsy drug BHV-7000 https://pharmadog.xyz/news/387942 pharmadog en 2026-09-10T13:36:56.000Z FDA expands approval for Bayer's lung cancer therapy https://pharmadog.xyz/news/387922 pharmadog en 2026-09-10T13:26:46.000Z Drugmakers Rethink Launch Strategies as MFN Pricing Rules Shake Market https://pharmadog.xyz/news/387843 pharmadog en 2026-09-10T13:09:22.000Z Novartis shareholder urges board overhaul after share plunge tied to trial setbacks https://pharmadog.xyz/news/387923 pharmadog en 2026-09-10T13:07:09.000Z Encoded Therapeutics secures $275M Series F to advance gene therapy for Dravet syndrome https://pharmadog.xyz/news/387844 pharmadog en 2026-09-10T13:01:00.000Z Cancer drug shortages persist at US centers, survey shows many face multiple medication gaps https://pharmadog.xyz/news/387823 pharmadog en 2026-09-10T12:24:41.000Z Tyra Biosciences shares tumble as bladder cancer pill shows lower-than-expected complete response https://pharmadog.xyz/news/387631 pharmadog en 2026-09-10T12:00:24.000Z Oura files S-1, outlining its plans to expand into healthcare as it prepares for IPO https://pharmadog.xyz/news/387735 pharmadog en 2026-09-10T11:45:00.000Z Reverse mergers surge as biotech firms seek public listings via shell companies https://pharmadog.xyz/news/387695 pharmadog en 2026-09-10T11:34:59.000Z CMS chief Mehmet Oz touts AI avatars for rural health, but some hospital leaders remain skeptical https://pharmadog.xyz/news/387632 pharmadog en 2026-09-10T11:09:03.000Z BridgeBio Oncology shares tumble 24% as it narrows KRAS program focus https://pharmadog.xyz/news/387675 pharmadog en 2026-09-10T11:08:18.000Z CDMOs Redefine Pharma Supply Chains with AI, Cold-Chain Logistics and Smart Sourcing https://pharmadog.xyz/news/387568 pharmadog en 2026-09-10T10:30:00.000Z Roivant's mosliciguat shows strong efficacy in Phase 2 PH-ILD trial https://pharmadog.xyz/news/387567 pharmadog en 2026-09-10T10:30:00.000Z UniQure to release four-year Huntington’s gene therapy results by September https://pharmadog.xyz/news/388158 pharmadog en 2026-09-10T10:09:00.000Z Novartis shareholder urges board overhaul after costly Avidity acquisition setbacks https://pharmadog.xyz/news/388160 pharmadog en 2026-09-10T10:03:00.000Z FDA places partial hold on Biohaven epilepsy drug BHV-7000 amid $350 million licensing deal https://pharmadog.xyz/news/388161 pharmadog en 2026-09-10T09:45:00.000Z Frazier Life Sciences raises over $1.1 billion for its public biotech fund, now $2.8 billion total https://pharmadog.xyz/news/387990 pharmadog en 2026-09-10T09:25:00.000Z Takeda R&D chief Andy Plump to retire after string of recent FDA approvals https://pharmadog.xyz/news/387232 pharmadog en 2026-09-10T08:30:00.000Z Senator John Fetterman's post-stroke conduct sparks debate on brain health and politics https://pharmadog.xyz/news/387233 pharmadog en 2026-09-10T08:30:00.000Z Trump administration touts AI as solution for rural health care, experts remain skeptical https://pharmadog.xyz/news/387234 pharmadog en 2026-09-10T08:30:00.000Z Midterm races in Iowa, Florida and others could shape US vaccine policy https://pharmadog.xyz/news/386889 pharmadog en 2026-09-10T07:00:00.000Z August 2026 biopharma layoffs affect just over 500 workers, a 90% drop from a year earlier https://pharmadog.xyz/news/386888 pharmadog en 2026-09-10T07:00:00.000Z AI transforms talent strategy in life-science companies, moving from tools to strategic intelligence https://pharmadog.xyz/news/386887 pharmadog en 2026-09-10T07:00:00.000Z BioSpace reports 11 California biopharma firms posting over 400 jobs as openings rise 31% YoY https://pharmadog.xyz/news/386695 pharmadog en 2026-09-10T06:00:03.000Z Pharma investment in UK rises as government increases drug pricing and engagement https://pharmadog.xyz/news/386611 pharmadog en 2026-09-10T04:42:00.000Z FDA proposes 50% fee cut for US early-stage trials, but industry says speed matters more https://pharmadog.xyz/news/134233 pharmadog en 2026-09-09T23:22:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/385587 pharmadog en 2026-09-09T23:01:00.000Z UK commission proposes new framework to regulate AI-driven medical tools https://pharmadog.xyz/news/388159 pharmadog en 2026-09-09T22:20:00.000Z Massachusetts governor warns early-stage biotech firms of capital crunch ahead of election https://pharmadog.xyz/news/385311 pharmadog en 2026-09-09T21:44:07.000Z Two infants die in Pennsylvania measles outbreak, coroner confirms one death caused by virus https://pharmadog.xyz/news/385223 pharmadog en 2026-09-09T19:46:00.000Z Tyra Biosciences’ bladder cancer pill misses expected response rate in Phase 2 trial https://pharmadog.xyz/news/384607 pharmadog en 2026-09-09T17:47:06.000Z Encoded Therapeutics raises $275 million in Series F round for Dravet syndrome program https://pharmadog.xyz/news/384608 pharmadog en 2026-09-09T17:44:20.000Z ARPA-H selects UpDoc, Tempus AI and Atman Health for new AI heart-disease program https://pharmadog.xyz/news/384499 pharmadog en 2026-09-09T16:51:11.000Z Researchers urge FDA to adopt EMA-style drug rejection letter disclosures https://pharmadog.xyz/news/384287 pharmadog en 2026-09-09T16:01:00.000Z ARPA-H commits $62.7 million to develop FDA-authorized AI for heart-failure treatment https://pharmadog.xyz/news/384416 pharmadog en 2026-09-09T15:54:00.000Z Kura Oncology launches Caspian Therapeutics to develop menin-inhibitor diabetes drug with $50M funding https://pharmadog.xyz/news/384223 pharmadog en 2026-09-09T15:43:28.000Z Research on orexin and narcolepsy earns Lasker Award for Yanagisawa and Mignot https://pharmadog.xyz/news/384224 pharmadog en 2026-09-09T15:35:07.000Z Compass Pathways reports positive one-year data for its psilocybin therapy COMP360 https://pharmadog.xyz/news/384179 pharmadog en 2026-09-09T15:04:00.000Z FDA appoints permanent heads of CDER and CBER, adding AI deputy role https://pharmadog.xyz/news/384159 pharmadog en 2026-09-09T14:58:55.000Z AI cannot solve emergency-room woes, highlighting broader health-care challenges https://pharmadog.xyz/news/383992 pharmadog en 2026-09-09T13:56:42.000Z Webinar explores how GLP-1 obesity drugs are reshaping US healthcare and market dynamics https://pharmadog.xyz/news/386010 pharmadog en 2026-09-09T13:52:00.000Z nPhase unveils AI-driven clinical data platform to accelerate trial design and submission https://pharmadog.xyz/news/384011 pharmadog en 2026-09-09T13:38:20.000Z Scientists who discovered orexin receive Lasker Award as FDA appoints permanent heads of key drug and biologics centers https://pharmadog.xyz/news/384012 pharmadog en 2026-09-09T13:15:57.000Z AstraZeneca's COPD drug cuts flare-ups in late-stage trials, offering new option for patients https://pharmadog.xyz/news/383864 pharmadog en 2026-09-09T13:00:53.000Z Sandoz to invest $1 billion in European biosimilar hub, targeting 100 biosimilars by 2040 https://pharmadog.xyz/news/383865 pharmadog en 2026-09-09T12:05:41.000Z Novo Nordisk halts two IL-6 heart trials as Novartis suffers Phase 3 setbacks; Ionis wins first Alexander disease approval https://pharmadog.xyz/news/383716 pharmadog en 2026-09-09T12:00:42.000Z FDA makes acting CBER and CDER heads permanent, signaling leadership continuity https://pharmadog.xyz/news/383717 pharmadog en 2026-09-09T11:56:16.000Z BMS reports positive mid-stage results for arlo-cel in heavily pre-treated myeloma patients https://pharmadog.xyz/news/383607 pharmadog en 2026-09-09T11:53:36.000Z Telemedicine firm begins offering GLP-1 medications to treat addiction https://pharmadog.xyz/news/123087 pharmadog en 2026-09-09T11:38:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/383455 pharmadog en 2026-09-09T11:01:41.000Z NodThera rebrands as Rezera and targets Phase 3 trial in 2027 https://pharmadog.xyz/news/383479 pharmadog en 2026-09-09T11:01:00.000Z Solstice Oncology secures $225M Series A to launch FDA-cleared Phase 2 CTLA-4 antibody trial https://pharmadog.xyz/news/383456 pharmadog en 2026-09-09T11:00:54.000Z TwoStep Therapeutics raises $62.5 million Series A backed by Pfizer and Merck KGaA venture groups https://pharmadog.xyz/news/383457 pharmadog en 2026-09-09T11:00:49.000Z Kura Oncology spins out diabetes program into new company with $50M funding and Lilly support https://pharmadog.xyz/news/383458 pharmadog en 2026-09-09T11:00:48.000Z Beeline Medicines reports promising Phase 2 lupus data https://pharmadog.xyz/news/383459 pharmadog en 2026-09-09T11:00:08.000Z Tyra Biosciences reports Phase 2 success in low-risk bladder cancer, plans pivotal trial https://pharmadog.xyz/news/383499 pharmadog en 2026-09-09T11:00:00.000Z Caspian Therapeutics launches with $50M to develop menin inhibitors for diabetes and cardiometabolic disease https://pharmadog.xyz/news/383519 pharmadog en 2026-09-09T11:00:00.000Z Solstice Oncology secures $225M Series A to advance CTLA-4 antibody porustobart in colon cancer https://pharmadog.xyz/news/383480 pharmadog en 2026-09-09T11:00:00.000Z Caspian Therapeutics launches with $50M funding and Eli Lilly backing to develop menin inhibitor for diabetes https://pharmadog.xyz/news/384091 pharmadog en 2026-09-09T09:45:00.000Z Luma Group closes $410 million, 15-year life-science venture fund https://pharmadog.xyz/news/384092 pharmadog en 2026-09-09T09:43:00.000Z Encoded Therapeutics secures $275M Series F to push Dravet gene therapy and expand manufacturing https://pharmadog.xyz/news/383922 pharmadog en 2026-09-09T09:15:00.000Z Tyra Biosciences reports phase 2 bladder cancer data, complete response rates miss analyst targets, shares slide https://pharmadog.xyz/news/383924 pharmadog en 2026-09-09T09:01:00.000Z FDA appoints permanent heads for CDER and CBER amid pending commissioner confirmation https://pharmadog.xyz/news/384090 pharmadog en 2026-09-09T08:56:00.000Z Kura Oncology launches Caspian Therapeutics with $50M funding to develop next-generation diabetes drug https://pharmadog.xyz/news/383223 pharmadog en 2026-09-09T08:30:00.000Z Opinion: Autonomous AI could surpass AI-assisted doctors on key tasks by 2030 https://pharmadog.xyz/news/383224 pharmadog en 2026-09-09T08:30:00.000Z AMA chief says AI will augment, not replace, physicians https://pharmadog.xyz/news/383225 pharmadog en 2026-09-09T08:30:00.000Z AI tools struggle to improve emergency room workflow, study finds https://pharmadog.xyz/news/384335 pharmadog en 2026-09-09T08:11:00.000Z Abbott receives FDA clearance for TactiFlex Duo catheter, offering flexible AFib ablation options https://pharmadog.xyz/news/383011 pharmadog en 2026-09-09T07:38:48.000Z Evommune's MRGPRX2 antagonist fails second Phase 2b trial in atopic dermatitis https://pharmadog.xyz/news/382927 pharmadog en 2026-09-09T07:00:00.000Z Career setbacks offer data points, not definitive verdicts, says executive coach https://pharmadog.xyz/news/383430 pharmadog en 2026-09-09T04:23:00.000Z Beeline's oral lupus drug afimetoran meets primary endpoint in Phase 2, paving way for Phase 3 https://pharmadog.xyz/news/382543 pharmadog en 2026-09-09T04:20:00.000Z Biopharma looks beyond China to five alternative overseas markets amid rising geopolitical tensions https://pharmadog.xyz/news/382544 pharmadog en 2026-09-09T04:10:00.000Z Biotech crossover rounds projected to exceed $4.2 billion in 2026, supporting IPO pipeline https://pharmadog.xyz/news/383262 pharmadog en 2026-09-09T04:06:00.000Z Evommune gives up hope for MRGPRX2 antagonist to treat itch after latest phase 2 fail https://pharmadog.xyz/news/383923 pharmadog en 2026-09-09T02:05:00.000Z Labcorp acquires MLM Medical Labs to expand global lab network across four continents https://pharmadog.xyz/news/383432 pharmadog en 2026-09-09T00:08:00.000Z Solstice Oncology raises $225M Series A to push next-gen CTLA-4 antibody into Phase 2 colon cancer trial https://pharmadog.xyz/news/386001 pharmadog en 2026-09-09T00:00:00.000Z FDA appoints permanent heads of drug, biologics and tobacco centers and adds AI deputy commissioner https://pharmadog.xyz/news/381628 pharmadog en 2026-09-08T23:00:00.000Z Six AI agents run on a deskside system to deliver on-premises clinical decision support https://pharmadog.xyz/news/381371 pharmadog en 2026-09-08T21:15:40.000Z FDA makes permanent four key leadership appointments, including first AI deputy commissioner https://pharmadog.xyz/news/381200 pharmadog en 2026-09-08T21:07:50.000Z FDA makes CBER and CDER leaders permanent amid pending commissioner confirmation https://pharmadog.xyz/news/381421 pharmadog en 2026-09-08T19:31:00.000Z FreshPoint recalls 1,093 Cranberry Chicken Salad Sandwiches over undeclared egg allergen https://pharmadog.xyz/news/381244 pharmadog en 2026-09-08T18:41:00.000Z Roivant reports record-breaking Phase 2 results for PH-ILD drug mosliciguat, starts Phase 3 https://pharmadog.xyz/news/380855 pharmadog en 2026-09-08T18:29:02.000Z Pharvaris reports injectable-like efficacy from once-daily oral pill for rare genetic disease